40 Recruiting Colorectal Neoplasms Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Colorectal Neoplasms
Related Conditions
Top Recruiting Colorectal Neoplasms Studies
S0820, Adenoma and Second Primary Prevention Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔MyGI Diet for Colorectal Cancer Prevention
📍 University of Michigan — Ann Arbor, Michigan
View Study & Checklist ➔A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
📍 Banner MD Anderson — Gilbert, Arizona
View Study & Checklist ➔Combination Immunotherapy in Colorectal Cancer
📍 Weill Cornell Medicine/New York-Presbyterian Brooklyn Methodist Hospital — Brooklyn, New York
View Study & Checklist ➔Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
📍 UCSD Medical Center - Encinitas — Encinitas, California
View Study & Checklist ➔Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Increasing Breast and Colorectal Cancer Screening in the Community
📍 Henry Street Settlement — New York, New York
View Study & Checklist ➔Preventing Early-Onset Colorectal Cancer in the VA
📍 VA NY Harbor Healthcare System, New York, NY — New York, New York
View Study & Checklist ➔Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
📍 University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
📍 Florida Cancer Specialists — Sarasota, Florida
View Study & Checklist ➔A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
📍 Palo Verde Hematology Oncology — Glendale, Arizona
View Study & Checklist ➔Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔TES RCT Fleet Enema vs Oral Mechanical Bowel Prep
📍 Victoria General Hospital — Halifax, Nova Scotia
View Study & Checklist ➔A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
📍 Mayo Clinic Hospital — Phoenix, Arizona
View Study & Checklist ➔DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
📍 RWJBarnabas Health Clara Maas Medical Center — Belleville, New Jersey
View Study & Checklist ➔Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Fecal Immunochemical Test for Post-polypectomy Surveillance to Reduce Unnecessary eNdoscopy
📍 Forzani & Macphail Colon Cancer Screening Centre, University of Calgary — Calgary, Alberta
View Study & Checklist ➔Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host
📍 Princess Margaret Cancer Centre — Toronto, Ontario
View Study & Checklist ➔A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
📍 Ironwood Cancer and Research Center — Chandler, Arizona
View Study & Checklist ➔